Exopharm Share Price and Company Fundamentals



Price
$0.165
Change
0.000 (0.000%)
52 week
0.16 - 0.68

Last traded: Today at 5:45 AM

Exopharm Limited, a clinical-stage company, develops transformative medicines based upon extracellular vesicles (EVs) in Australia. The company's technology includes extracellular vesicle positioning system that allows specific molecules to be attached to the surface of exosomes to guide them to target tissues or cell types; leveraging oligonucleotide packing for amplified dosing, which enables specific RNA molecules to be preferentially loaded into exosomes as a therapeutic cargo; ligand-based exosome affinity purification that isolates and purifies exosomes from biofluids like blood and cell culture media. Its engineered EVs products comprise Fortrexo CoV for the treatment of SARS-CoV-2 infection; Cognevo for the treatment of neuro degeneration; and PlexoDox for the treatment of cancer. Exopharm Limited has a research collaboration with Showa Denko Materials Co., Ltd. The company was incorporated in 2013 and is based in Melbourne, Australia.

Key Metrics

PE ratio

-

PB ratio

2.50

Dividend yield

0.00%

Beta

1.10

Market cap

-

Enterprise value

-

Company profile

Primary activitiesBiopharmaceutical research with a primary focus on developing and commercialising exosomes as therapeutic agents.
Industry / SectorBiotechnology / Healthcare
Full time employees41
Websitehttps://www.exopharm.com
Mailing address31 Queen Street Level 17 Melbourne VIC 3000 Australia
Phone / Fax61 3 9111 0026 /
Share registryAUTOMIC REGISTRY SERVICES

Dividends

More: Exopharm Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Exopharm paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.EX1 dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

EX1's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of May 2022, following are the company executives and directors listed on Exopharm.

NameTitleAgeTotal Pay
Dr. Ian E. Dixon M.A.I.C.D., M.B.A., MBA, Ph.D.Founder, Technology Co-Founder, CEO MD & Director430.38k
Dr. Gregor Lichtfuss M.Sc.Co-Founder & Bus. Services Mang.228.54k
Mr. Johannes MuhlSr. VP of Fin.
Daisy ScarboroughChief Operating Officer
Dr. Michael L. West Ph.D.Chief Technology Officer57
Caitlin GladmanVP of Communications
Mr. David OxleyPres of International
Mr. David James Franks B.Ec, BEc, CA, F Fin, JP.Company Sec.51

Profitability and management effectiveness

Profit margin

-242.77%

Operating margin

-242.94%

Return on assets

-48.57%

Return on equity

-97.38%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Exopharm is and its enterprise value is .

The EX1's stocks Beta value is 1.10 making it 10% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Exopharm (EX1)

Exopharm (ASX:EX1) Frequently Asked Questions

1. What is Exopharm's Stock Symbol?

Exopharm trades on ASX under the ticker symbol "EX1".

2. What is Exopharm's stock price today?

One share of EX1 stock can currently be purchased for approximately $0.165.

3. How can I contact Exopharm?

Exopharm's mailing address is 31 Queen Street Level 17 Melbourne VIC 3000 Australia. The company can be reached via phone at 61 3 9111 0026.

4. What is Exopharm's official website?

The official website of Exopharm is https://www.exopharm.com.

5. Which share registry manages Exopharm's stock?

Exopharm's stock is managed by AUTOMIC REGISTRY SERVICES.